The Macro Ledger of Medical AI: Why Doximity’s Hype Misses the Infrastructure Play

The ledger remembers what the market forgets. In the past seven days, Doximity’s stock surged 18% on the back of a single AI integration announcement—a sentiment-driven spike that tells me more about the market’s hunger for narrative than about sustainable value creation. I have seen this pattern before: in 2017, ICO projects with nothing but a whitepaper and a celebrity advisor raised $50 million overnight. The market is again confusing utility with hype, and this time it’s happening in medical AI. Doximity, a platform connecting healthcare professionals, announced a new AI-powered clinical documentation tool. Headlines call it a “revolution.” But as a macro strategy analyst who has spent five years dissecting digital asset trends, I see a different story: the underlying infrastructure for secure, interoperable medical data remains fragmented and vulnerable. The real opportunity—and the real risk—lies in how we build the consensus layer for healthcare data. And that is where blockchain enters the picture. Based on my experience auditing 200+ smart contracts during the ICO era, I learned that code is law only until the regulator steps in. Medical data is the most sensitive asset class on the planet. It cannot be stored on a public ledger without extreme privacy safeguards. Yet Doximity’s AI tool, like most of its competitors, relies on centralized cloud servers. In 2023, a single breach at a major health system exposed 4 million patient records. The market is pricing Doximity as if it has solved the data governance problem, but the technology stack does not support that claim. Let us look at the macro context. Global healthcare spending is projected to reach $10 trillion by 2025. AI in healthcare alone is a $200 billion opportunity. But the foundational layer—data liquidity and security—is still handled by legacy systems. The irony is that the healthcare industry, which demands the highest level of standardization, is one of the most fragmented. Every hospital, every clinic, every insurer uses a different EHR system. Doximity’s AI only works if it can access clean, structured data. But the data is siloed, inconsistent, and often subject to HIPAA restrictions that make cross-institutional sharing a legal minefield. This is where the contrarian angle emerges. The market views Doximity’s AI as a direct revenue driver. I view it as a proof-of-concept for a much larger infrastructure need: a standardized, permissioned blockchain for medical data. Do not mistake me—I am not advocating for a public, permissionless ledger for patient records. The regulatory constraints are too heavy. But a consortium blockchain, like the one used by the FDA for the Drug Supply Chain Security Act, could provide a shared, auditable, and secure data layer. The ledger remembers every consent, every access, every modification. That is the base layer upon which AI can be safely deployed. We do not build on hype; we build on consensus. Consensus here means agreement on data standards, identity management, and audit trails. The current Doximity hype cycle ignores the fact that without a standardized data infrastructure, the AI model will be trained on noisy, incomplete, and potentially biased data. The output will be only as good as the input. In my 2022 analysis of the Terra/Luna collapse, I noted that algorithmic stablecoins failed because they lacked a robust collateral layer. The same principle applies to medical AI: without a robust data layer, the AI is built on sand. Let me quantify this. During my work on a compliance framework for a Spot Bitcoin ETF in 2024, I designed a standardized custody solution that reduced institutional onboarding time by 25%. The same principle applies here: a standardized data layer, built on a permissioned blockchain with smart contracts for consent management, could reduce the cost of data interoperability by 30-40% according to industry estimates. Doximity’s AI tool, if integrated with such a layer, would become exponentially more valuable. But the company is not investing in the infrastructure; it is investing in the application. That is a short-term play. The market is pricing Doximity as if it is the only game in town. But the real winners will be the projects that build the rails—the consensus layer for medical data. I have seen this movie before. In 2020, during DeFi Summer, the protocols that provided liquidity infrastructure (Uniswap, Aave) outperformed the applications that simply used that liquidity. The same is true here. The healthcare data infrastructure market is still nascent. A few projects—like Medicalchain, Solve.Care, and even Hyperledger-based consortia—are working on it. But they lack the user base of Doximity. The optimal strategy would be for Doximity to acquire or partner with one of these infrastructure plays. But the current market narrative is all about AI, not about the data layer. The contrarian trade, therefore, is to short the hype and accumulate the infrastructure. When the inevitable data breach or regulatory backlash hits the medical AI sector, the market will suddenly remember that security and standardization matter. The ledger remembers what the market forgets. At that point, the infrastructure projects will be repriced upward. The macro trend is clear: healthcare is moving toward value-based care, which requires data liquidity. Data liquidity requires standardization. Standardization requires blockchain. The cycle is predictable. Trust no one, verify everything. That is the motto of the medical data infrastructure. Doximity’s AI tool, while impressive, does not solve the verification problem. It simply processes data faster. The next bull run in healthcare technology will not be led by AI applications, but by the infrastructure that makes AI safe. As a macro watcher, I am positioning for that rotation. The current sideways market is the perfect time to build that position. Chop is for positioning. Use the technical signals—rising institutional interest in healthcare blockchain projects, flat price action in Doximity’s stock after the initial pump—to identify the undervalued plays. In conclusion, the medical AI hype is a distraction. The real opportunity lies in the data layer. The ledger remembers what the market forgets, and the market has forgotten the importance of infrastructure. When the regulator steps in, and they will, the only projects that survive will be those built on a foundation of consensus, standardization, and security. That is the macro strategy for the next cycle.